Show simple item record

dc.contributor.authorKarande, I.
dc.contributor.authorGoff, Z.
dc.contributor.authorKewley, J.
dc.contributor.authorMehta, S.
dc.contributor.authorSnelling, Thomas
dc.date.accessioned2018-04-30T02:41:08Z
dc.date.available2018-04-30T02:41:08Z
dc.date.created2018-04-16T07:41:36Z
dc.date.issued2017
dc.identifier.citationKarande, I. and Goff, Z. and Kewley, J. and Mehta, S. and Snelling, T. 2017. Dose-banding of intravenous piperacillin-tazobactam in pediatric surgical inpatients. Journal of Pediatric Pharmacology and Therapeutics. 22 (5): pp. 364-368.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/66541
dc.identifier.doi10.5863/1551-6776-22.5.364
dc.description.abstract

© Published by the Pediatric Pharmacy Advocacy Group. All rights reserved. BACKGROUND Antimicrobial doses in children are often prescribed by using an individually calculated dose per weight (e.g., mg/kg) or based on body surface area. Dosing errors are the most commonly reported medication errors in children. A “dose-banding” strategy is frequently used for some over-the-counter drugs to prevent dosing errors. It could also lead to efficiencies by enabling batch preparation of intravenous (IV) medications in hospitals. OBJECTIVES To evaluate whether use of dose-banding for IV piperacillin-tazobactam results in acceptable dose variation from standard practice of individualized prescription of 100 mg/kg in children. METHODS We conducted a historically controlled intervention study comparing prescriptions of IV piperacillin-tazobactam before vs. after introduction of dose-banding prescribing guidance for surgical inpatients weighing > 5 kg and < 16 years of age at the tertiary referral pediatric hospital in Western Australia. RESULTS Dose-banding of IV piperacillin-tazobactam (with a maximum of 15% departure from the recommended milligram-per-weight dose of 100 mg/kg) resulted in similar overall variation of prescribed dose in comparison to individualized milligram-per-weight (non-dose-banded) prescribing. There was a trend toward fewer prescriptions with large variance ( > 30% variation from the 100-mg/kg dose) in the dose-banded compared to the non-dose-banded group (1/140 vs. 5/105; p = 0.09). CONCLUSIONS Our study showed dose-banding of IV piperacillin-tazobactam resulted in acceptable variation when compared to individualized milligram-per-weight dosing in children. Prospectively designed controlled trials are warranted to determine whether dose-banding could reduce medication errors and optimize use of hospital resources. Implications for future practice could include faster batch preparation, shorter checking and dispensing time, and reduction in drug wastage.

dc.titleDose-banding of intravenous piperacillin-tazobactam in pediatric surgical inpatients
dc.typeJournal Article
dcterms.source.volume22
dcterms.source.number5
dcterms.source.startPage364
dcterms.source.endPage368
dcterms.source.issn1551-6776
dcterms.source.titleJournal of Pediatric Pharmacology and Therapeutics
curtin.departmentSchool of Public Health
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record